Effectiveness of sofosbuvir, ledipasvir/sofosbuvir, or paritaprevir/ritonavir/ombitasvir and dasabuvir regimens for treatment of patients with hepatitis C in the veterans affairs national health care system (vol 151, pg 457, 2016)

被引：0
|
作者：
Ioannou, G. N.
Beste, L. A.
Chang, M. F.
机构：
来源：
GASTROENTEROLOGY | 2016年 / 151卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1253 / 1253
页数：1
相关论文
共 35 条
  • [1] Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir, or Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C in the Veterans Affairs National Health Care System
    Ioannou, George N.
    Beste, Lauren A.
    Chang, Michael F.
    Green, Pamela K.
    Lowy, Elliott
    Tsui, Judith I.
    Su, Feng
    Berry, Kristin
    GASTROENTEROLOGY, 2016, 151 (03) : 457 - +
  • [2] Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir and Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir-Based Antiviral Regimens for Hepatitis C in 17,847 patients in the Veterans Affairs National Healthcare System
    Ioannou, George N.
    Beste, Lauren A.
    Chang, Michael
    Green, Pamela
    Lowy, Elliott
    Tsui, Judith
    Su, Feng
    Berry, Kristin
    HEPATOLOGY, 2016, 64 : 11A - 11A
  • [3] EFFECTIVENESS OF LEDIPASVIR/SOFOSBUVIR AND OMBITASVIR/PARITAPREVIR/RITONAVIR/DASABUVIR IN TREATMENT-NAIVE AND -EXPERIENCED US VETERANS WITH GENOTYPE 1 HEPATITIS C INFECTION
    Fuchs, M.
    Forte, V.
    Tassone, D.
    Owens, S.
    Garcia, C.
    Obolewicz, B.
    Solomon, C.
    Gilles, H.
    Gavis, E.
    Heuman, D.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S797 - S798
  • [4] Effectiveness, treatment completion and safety of sofosbuvir/ledipasvir and paritaprevir/ritonavir/ombitasvir plus dasabuvir in patients with chronic kidney disease: an ERCHIVES study
    Butt, A. A.
    Ren, Y.
    Puenpatom, A.
    Arduino, J. M.
    Kumar, R.
    Abou-Samra, A-B.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (01) : 35 - 43
  • [5] CORRELATES OF TWELVE WEEK TREATMENT ADHERENCE AMONG PATIENTS WITH HEPATITIS C NEWLY INITIATING DIRECT ACTING ANTIVIRAL THERAPIES INCLUDING SOFOSBUVIR CONTAINING, LEDIPASVIR/SOFOSBUVIR AND OMBITASVIR/PARITAPREVIR/RITONAVIR-DASABUVIR REGIMENS
    Shcherbakova, N.
    Tereso, G.
    Colby, A.
    D'Angelo, L.
    VALUE IN HEALTH, 2017, 20 (05) : A185 - A185
  • [6] Effect of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir and Ledipasvir/Sofosbuvir Regimens on Survival Compared With Untreated Hepatitis C Virus-Infected Persons: Results From ERCHIVES
    Butt, Adeel Ajwad
    Yan, Peng
    Simon, Tracey G.
    Abou-Samra, Abdul-Badi
    CLINICAL INFECTIOUS DISEASES, 2017, 65 (06) : 1006 - 1011
  • [7] Real-world efficacy and safety of Ledipasvir plus Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience
    Degertekin, Bulent
    Demir, Mehmet
    Akarca, Ulus S.
    Kani, Haluk Tarik
    Ucbilek, Enver
    Yildirim, Emre
    Guzelbulut, Fatih
    Balkan, Ayhan
    Vatansever, Sezgin
    Danis, Nilay
    Demircan, Melek
    Soylu, Aliye
    Yaras, Serkan
    Kartal, Aysun
    Kefeli, Ayse
    Gunduz, Feyza
    Yalcin, Kendal
    Erarslan, Elife
    Aladag, Murat
    Harputluoglu, Murat
    Ozakyol, Aysegul
    Temel, Tuncer
    Akarsu, Mesut
    Sumer, Hale
    Akin, Mete
    Albayrak, Bulent
    Sen, Ilker
    Alkim, Huseyin
    Uyanikoglu, Ahmet
    Irak, Kader
    Oztaskin, Sinem
    Ugurlu, Cagri Burak
    Gunes, Sevkican
    Gurel, Selim
    Nuriyev, Kenan
    Inci, Ismail
    Kacar, Sabite
    Dincer, Dinc
    Doganay, Levent
    Gokturk, Huseyin Savas
    Mert, Ali
    Cosar, Arif Mansur
    Dursun, Hakan
    Atalay, Roni
    Akbulut, Sabiye
    Balkan, Yasemin
    Koklu, Hayrettin
    Simsek, Halis
    Ozdogan, Osman
    Coban, Mehmet
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2020, 31 (12): : 883 - 893
  • [8] Treatment uptake and real world effectiveness of sofosbuvir/ledipasvir and paritaprevir/ritonavir/ombitasvir/dasabuvir among HCV-infected persons with chronic kidney disease
    Alkadi, M. M.
    Ren, Y.
    Puenpatom, A.
    Kumar, R.
    Arduino, J. M.
    Abou-Samra, A-B
    Butt, A. A.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S724 - S725
  • [9] TREATMENT UPTAKE AND REAL WORLD EFFECTIVENESS OF SOFOSBUVIR/LEDIPASVIR AND PARITAPREVIR/RITONAVIR/OMBITASVIR/DASABUVIR AMONG HCV-INFECTED PERSONS WITH CHRONIC KIDNEY DISEASE
    Alkadi, Mohamad
    Ren, Yanjie
    Puenpatom, Amy
    Kumar, Ritesh
    Arduino, Jean Marie
    Abou-Samra, Abdul-Badi
    Butt, Adeel
    GASTROENTEROLOGY, 2017, 152 (05) : S1100 - S1101
  • [10] Effectiveness of Ledipasvir/Sofosbuvir±Ribavirin and Ombitasvir/Paritaprevir/Ritonavir plus Dasabuvir±Ribavirin in 996 Genotype 1 HIV/HCV Coinfected Patients Treated in Routine Practice
    Belperio, Pamela S.
    Bhattacharya, Debika
    Shahoumian, Troy A.
    Loomis, Timothy P.
    Goetz, Matthew B.
    Mole, Larry A.
    Backus, Lisa I.
    HEPATOLOGY, 2016, 64 : 957A - 958A
1234